Allan H Friedman

发表

History of awake mapping and speech and language localization: from modules to networks.

Hugues Duffau, Shervin Rahimpour, Michael M Haglund, 2019, Neurosurgical focus.

fMRI activation mapping as a percentage of local excitation: Consistent presurgical motor maps without threshold adjustment

James T Voyvodic, Allan H Friedman, Jeffrey R Petrella, 2009, Journal of magnetic resonance imaging : JMRI.

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

John Sampson, Allan H Friedman, A. Friedman, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of temozolomide in patients with progressive low-grade glioma.

Allan H Friedman, James M Provenzale, R. McLendon, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Raymond Sawaya, Allan H Friedman, Mark R Gilbert, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.

Allan H Friedman, R. McLendon, A. Friedman, 2009, Neuro-oncology.

Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).

Allan H Friedman, R. McLendon, A. Friedman, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

Mitchel S Berger, Allan H Friedman, James M Provenzale, 2008, Neuro-oncology.

INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION‐ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS: DESCRIPTIVE EFFECTS OF TARGET ANATOMY AND CATHETER POSITIONING

Christoph Pedain, Allan H Friedman, Raj K Puri, 2007, Neurosurgery.

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.

Allan H Friedman, James M Provenzale, R. McLendon, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.

Allan H Friedman, R. McLendon, A. Friedman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.

Raghu Raghavan, Christoph Pedain, Allan H Friedman, 2007, Neuro-oncology.

Phase II trial of gefitinib in recurrent glioblastoma.

Allan H Friedman, R. McLendon, A. Friedman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.